Avenue therapeutics announces new drug application for iv tramadol accepted for review by fda

Avenue therapeutics announces new drug application for iv tramadol accepted for review by fda.avenue therapeutics inc - fda set a prescription drug user fee act ("pdufa") goal action date of october 10, 2020.

ATXI Ratings Summary

ATXI Quant Ranking